The role of combined metal interactions in metal carcinogenesis: A review

Reviews on Environmental Health

Volumn 18, Issue 2, 2003, Pages 91-109

  Madden, Emily F ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Cancer; DNA; Epidemiology; Free radicals; Mixtures; Risk assessment

Indexed keywords

ARSENIC; BERYLLIUM; CADMIUM; CHROMIUM; DNA; FREE RADICAL; LEAD; MERCURY; METAL; NICKEL;

CANCER; CANCER EPIDEMIOLOGY; CARCINOGENESIS; DNA METHYLATION; DNA REPAIR; DNA REPLICATION; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; HUMAN; LIPID PEROXIDATION; METAL CARCINOGENESIS; MOLECULAR INTERACTION; OCCUPATIONAL EXPOSURE; RESEARCH; REVIEW; RISK ASSESSMENT;

EID: 0141955249     PISSN: 00487554     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVEH.2003.18.2.91     Document Type: Review

References (151)

1. Kasprzak KS, Buzard G. The role of metals in oxidative damage and redox cell signaling derangement. In: Koropatnick J, Zalups R, eds, Molecular Biology and Toxicology of Metals. London, UK: Taylor and Francis, 2000; 477-527.
2. Pershagen G, Wall S, Taube A, Linnman L. On the interaction between occupational arsenic exposure and smoking and its relationship to lung cancer. Scand J Work Environ Health 1981; 7: 302-309.
3. Lee AM, Fraumeni JF Jr. Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst 1969; 42: 1045-1052.
4. Gerhardsson L, Nordberg GF. Lung cancer in smelter workers: interactions of metals as indicated by tissue levels. Scand J Work Environ Health 1993; 19 Suppl 1: 90-94.
5. Piscator M. Cadmium and the cancer of the prostate. In: Wilson D, Volpe RA, eds, Cadmium 81. Edited Proceedings of the Third International Cadmium Conference Miami. London, UK: Cadmium Association 1982; 135-137.
6. Snow E. Metal carcinogenesis: mechanistic implications. Pharmac Ther 1992; 53: 31-65.
7. Magos L. Epidemiological and experimental aspects of metal carcinogenesis: Physiochemical properties, kinetics, and the active species. Environ Health Perspec 1991; 95: 157-189.
8. International Agency for Research on Cancer. Carcinogenesis of arsenic compounds. In: IARC Monograph on Evaluation of Carcinogenic Risk to Humans. Lyon, France: IARC, 1980; 23: 37-141. (summarized in http://www.inchem.org/documents/iarc/vo123/arsenic.html)
9. Chen CJ, Chen CW, Wu MM, Kuo TL Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 1992; 66: 888-892.
10. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS, et al. Incidence of internal cancers and ingested inorganic arsenic: A seven years follow up study in Taiwan. Cancer Res 1995; 55: 1296-1300.
11. International Agency for Research on Cancer. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans, Overall Evaluations of Carcinogenicity, Update of IARC Monograph, Vols, 1-42, Suppl 7. Lyon, France: IARC, 1987; 100-106.
12. Stohrer G. Arsenic: opportunity for risk assessment. Arch Toxicol 1991; 65: 525-531. Review.
13. Chan P, Huff J, Arsenic carcinogenesis in animals and in humans: mechanistic, experimental and epidemiological evidence. Environ Carcinog Ecotoxicol Rev C 1997; 15: 83-122.
14. Jacobson-Kram D, Montalbano D. The reproductive effects assessment group's report on the mutagenicity of inorganic arsenic. Environ Mutagen 1985; 7: 787-804.
15. Li JH, Rossman TG. Comutagenesis of sodium arsenite with ultraviolet radiation in Chinese hamster V79 cells. BioMetals 1991; 4: 197-200.
16. Yang JL, Chen MF, Wu CW, Lee TC. Post-treatment with sodium arsenite alters the mutational spectrum induced by ultraviolet light irradiation in Chinese hamster ovary cells. Environ Mol Mutagen 1992; 20: 156-164.
17. Li JH, Rossman TG. Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol Toxicol 1989; 2: 1-9.
18. Rossman TG. Enhancement of UV-mutagenesis by low concentrations of arsenite in E. coli. Mutat Res 1981; 91: 207-211.
19. Yager JW; Wiencke JK. Enhancement of chromosomal damage by arsenic: implications for mechanism. Environ Health Perspect 1993; 101 Suppl 3: 79-82.
20. Hartwig A. Current aspects in metal carcinogenicity. BioMetals 1995; 8: 3-11.
21. Hartwig A, Carcinogenecity of metal compounds: possible role of DNA repair inhibition. Toxicol Lett 1998; 102-103: 235-239. Review.
22. Hartwig A, Groblinghoff U, Beyersmann D, Natarajan A, Filon R, Mullenders L. Interaction of arsenic (III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis 1997; 18: 399-405.
23. DiPaolo JA, Casto BC. Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts. Cancer Res 1979; 39: 1008-1013.
24. Mass MG. Human carcinogenesis by arsenic. Environ Geochem Health 1992; 14: 49-54.
25. Hartmann A, Speit G. Comparative investigations of the genotoxic effects of metals in the single gel (SCG) assay and sister chromatid exchange (SCE) test. Environ Mol Mutagen 1994; 23: 299-305.
26. Mass MJ, Wang L. Arsenic alters cytosine methylation patterns of the promoter of tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 1997; 386: 263-277.
27. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA 1997; 94: 10907-10912.
28. Goering PL, Aposhian HV, Mass MJ, Cebrian M, Beck BD, Waalkes MP. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol Sci 1999; 49: 5-14.
29. Hei TK, Liu SX, Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc Natl Acad Sci USA. 1998; 95: 8103-8107.
30. Ramos O, Carrizales L, Yanez L, Mejia J, Batres L, Ortiz D, Diaz-Barriga F. Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels. Environ Health Perspect 1995; 103 Suppl 1: 85-88.
31. Rojas E, Herrera LA, Poirier LA, Ostrosky-Wegman P. Are metals dietary carcinogens? 1999; 443: 157-181. Review.
32. Kasprzak KS. Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis. Free Radic Biol Med. 2002; 32: 958-967.
33. International Agency for Research on Cancer. Beryllium and beryllium compounds. In: IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon, France: IARC, 1993; 58: 41-117.
34. MacMahon B. The epidemiological evidence on the carcinogenicity of beryllium in humans. 1994; 36: 15-24; discussion 25-6. Review.
35. World Health Organization International Programme on Chemical Safety. Concise International Chemical Assessment Document No. 32. Beryllium and Beryllium Compounds. Geneva Switzerland: WHO, 2001.
36. Reeves A. The carcinogenicity of beryllium. In: Brown S, Kodama Y, eds, Toxicology of Metals: Clinical and Experimental Research. Chichester, UK: Ellis Horwood Ltd., 1987; 245-246.
37. Skilleter D. Biochemical properties of beryllium potentially relevant to its carcinogenicity. In: Merian E, Frei R, Hardi W, Schlatter C, eds, Carcinogenic and Mutagenic Metal Compounds. Environmental and Analytical Chemistry and Biological Effects. New York, NY, USA: Gordon & Breach Science Publishers, 1985; 371-386.
38. Ashby J, Ishidate M Jr, Stoner GD, Morgan MA, Ratpan F, Callander RD. Studies on the genotoxicity of beryllium sulphate in vitro and in vivo. Mutat Res 1990; 240: 217-225.
39. World Health Organization Environmental Health Criteria. EHC 106: Beryllium. Geneva, WHO, 1990; 181.
40. Dunkel VC, Pienta RJ, Sivak A, Traul KA. Comparative neoplastic transformation responses of Balb/3T3 cells, Syrian Hamster embryo cells and Rauscher murine leukemia virus infected Fischer 344 rat embryo cells to chemical carcinogens. J Natl Cancer Inst 1981; 67: 1303-1312.
41. Williams BE, Skilleter DN. Inhibition of nuclear-protein phosphorylation in vitro by beryllium. Biosci Rep 1983; 3: 955-962.
42. Nelson N. Comments on the carcinogenicity and mutagenicity of metals and their compounds. In: Merian E, Frei RW, Hardi W, Schlatter C, eds., eds, Carcinogenic and Mutagenic Metal Compounds. New York, NY, USA: Gordon & Breach Science Publishers, 1985; 513-527.
43. Miyaki M, Murata I, Osabe M, Ono T. Effect of metal cations on misincorporation by E. coli DNA polymerases. Biochem Biophys Res Commun 1977; 77: 854-860.
44. Luke MZ, Hamilton L, Hollocher TC. Beryllium-induced misincorporation by a DNA polymerase. Biochem Biophys Res Commun 1975; 62: 497-501.
45. Leonard A, Lauwerys R. Mutagenicity, carcinogenicity and teratogenicity of beryllium. Mutat Res 1987; 186: 35-42.
46. Brooks AL, Griffith WC, Johnson NF, Finch GL, Cuddihy RG. The induction of chromosome damage in CHO cells by beryllium and radiation given alone and in combination. Radiat Res 1989; 120: 494-507.
47. International Agency for Research on Cancer. Beryllium, cadmium, and mercury exposures in the glass manufacturing industry. In: IARC Monograph on Evaluation of Carcinogenic Risk to Humans. Lyon, France: IARC, 1993; 58: 119-238.
48. Waalkes MP, Rehm S. Chronic toxic and carcinogenic effects of cadmium chloride in male DBA/2NCr and NFS/NCr mice: strain-dependent association with tumors of the hematopoietic system, injection site, liver, and lung. Fundam Appl Toxicol 1994; 23: 21-31.
49. Waalkes MP, Oberdorster. In: Foulkes E, ed, Biological Effects of Heavy Metals, Vol. 2. Mechanisms of Metal Carcinogenesis, Boca Raton, Florida, USA: CRC Press, 1990; 129-157.
50. Oberdorster G, Cherian MG, Baggs RB. Correlation between cadmium-induced pulmonary carcinogenicity, metallothionein expression and inflammatory processes: a species comparison. Environ Health Perspect 1994; 102 Suppl 3: 257-263.
51. 2+ ions and DNA. J Inorg Biochem. 2002; 90: 97-105.
52. Shimada H, Shiao Y, Shibata M, Waalkes MP. Cadmium suppresses apoptosis induced by chromium. J Toxicol Environ Health A. 1998; 54: 159-168.
53. Hartwig A. Role of DNA repair inhibition in lead-and cadmium-induced genotoxicity: A review. Environ Health Perspect 1994; 102 Suppl 3: 45-50. Review.
54. Sarkar B. Metal replacement in DNA-binding zinc finger proteins and its relevance to mutagenecity and carcinogenicity through free radical generation. Nutrition. 1995; 11 Suppl: 646-649. Review.
55. Rossman TG, Roy NK, Lin WC. Is cadmium genotoxic? IARC Sci Publ. 1992; 118: 367-375.
56. Misra RR, Smith GT, Waalkes MP. Evaluation of the direct genotoxic potential of cadmium in four different rodent cell lines. Toxicology 1998; 126: 103-114.
57. Forni A. Comparison of chromosome aberrations and micronuclei in testing genotoxicity in humans. Toxicol Lett 1994; 72: 185-190.
58. Howard W, Moody W, Kochhar TS. Induction of chromosome changes by metal compounds in cultured CHO cells. Toxicol Lett 1991; 56: 179-186.
59. Yang, J-L., Chao, J-I and Lin, J-G. Reactive oxygen species may participate in the mutagenicity and mutational spectrum of cadmium in Chinese hamster ovary cells. Chem Res Toxicol 1996; 9: 1360-1367.
60. Hirano T, Yamaguchi Y, Kasai H. Inhibition of 8-hydroxyguanine repair testes after administration of cadmium chloride to GSH-depleted rats. Toxicol Appl Pharmacol 1997; 147: 9-14.
61. Lynn S, Lai HT, Kao SM, Lai J, Jan KY. Cadmium inhibits DNA starnd break rejoining in methyl methanesulfonate-treated CHO-KI cells. Toxicol Appl Pharmacol 1997; 144: 171-176.
62. Takahashi K, Suzuki M, Sekiguchi M, Kawazoe Y. Effect of metal metal ions on transcription of the ada gene which encodes 06-methylguanine-DNA methylotransferase of Escherichia coli. Chem Pharm Bull Tokyo 1992; 40: 2483-2486.
63. Hartwig A, Beyersmann D. Enhancement of UV-induced mutagenesis and sister-chromatid exchanges by nickel ions in V79 cells: evidence for inhibition of DNA repair. Mutat Res 1989; 217: 65-73.
64. Aoki K, Saenger W. Heavy metal ion interactions with deoxy nucleotides. X-ray crystal structures of orthorhombic and monoclinic forms of 2′-deoxy cytidine 5′-monophosphate complexed with Cd(II). J Inorg Biochem 1984; 20: 225-245.
65. Kasprzak KS. Possible role of oxidative damage in metal-induced carcinogenesis. Cancer Invest 1995; 13: 411-430. Review.
66. Waalkes MP, Poirier LA. In vitro cadmium-DNA interactions: cooperativity of cadmium binding and competitive antagonism by calcium, magnesium, and zinc. Toxicol Appl Pharmacol 1984; 75: 539-546.
67. International Agency for Research on Cancer. Nickel and nickel compounds. In: Chromium, Nickel and Welding. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon, France: IARC, 1990; 49: 205-323.
68. Bianchi V, Levis AG. Review of genetic effects and mechanisms of action of chromium compounds. Sci Total Environ 1988; 71: 351-355.
69. Langard S. Role of chemical species and exposure characteristics in cancer among persons occupationally exposed to chromium compounds. Scand J Work Environ Health 1993; 19 Suppl 1: 81-89
70. Leonard A, Lauwerys RR. Carcinogenicity and mutagenicity of chromium. Mutat Res 1980; 76: 227-239.
71. Koppen G, Verschaeve L. The alkaline comet test on plant cells: a new genotoxicity test for DNA strand breaks in Vicia faba root cells. Mutat Res 1996; 360: 193-200.
72. Petrilli F, De Flora S. Interpretations on chromium mutagenicity and carcinogenicity. In: Sorsa M, Vainio H, eds, Mutations in Our Environment. New York, NY, USA: Alan R. Liss, Inc., 1982; 453-464.
73. Imreh S, Radulescu D. Cytogenic effects of chromium in vivo and in vitro. Mutat Res 1982; 97: 192-193.
74. Cupo D, Wetterhahn K. Modification of chromium (VI)-induced DNA damage by glutathione and cytochromes p-450 in chicken embryo hepatocytes. Proc Natl Acad Sci USA 1985; 82: 6755-6759.
75. Liu K, Shi X. In vivo reduction of chromium (VI) and its related free radical generation. Mol Cell Biochem 2001; 222: 41-47.
76. Snow E. A possible role for chromium (III) in genotoxicity. Environ Health Perspect 1991; 92: 75-81.
77. Snow E, Xu L. Chromium (III) bound to DNA templates promotes increased polymerase processivity and decreased fidelity during replication in vitro. Biochemistry 1991; 30: 11238-11245.
78. International Agency for Research on Cancer. Lead and lead compounds, inorganic. In: IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 23. Lyon, France: IARC, 1987.
79. Englyst V, Lundström NG, Gerhardsson L, Rylander L, Nordberg G. Lung cancer risks among lead smelter workers also exposed to arsenic. Sci Total Environ 2001; 273: 77-82.
80. Waalkes MP. Metal carcinogenesis. In: Sarkar B, ed, Heavy Metals in the Environment. New York, NY, USA: Marcel Dekker, Inc., 2002; 121-145.
81. Vainio H. Lead and cancer-association or causation? Scand J Work Environ Health 1997; 23: 1-3.
82. Fu H, Boffetta P. Cancer and occupational exposure to inorganic lead compounds: a metaanalysis of published data. Occup Environ Med 1995; 52: 73-81.
83. Valverde M, Trejo C, Rojas E. Is the capacity of lead acetate and cadmium chloride to induce genotoxic damage due to direct DNA-metal interaction? Mutagenesis 2001; 16: 265-270.
84. Hayashi M. Lead toxicity in pregnant rat: II. Effects of low-level lead on δ-aminolevulinic acid dehydratase activity in maternal and fetal blood or tissue. Ind Health 1983; 21: 127-135.
85. Casto BC, Meyers J, di Paolo JA. Enhancement of viral transformation for the evaluation of the carcinogenic or mutagenic potential of inorganic metal slats. Cancer Res 1979; 39: 193-198.
86. Rossman TG, Molina M, Meyer LW. The genetic toxicology of metal compounds: I. Induction of prophage in E. coli WP2s(lambda). Environ Mutagen 1984; 6: 59-69.
87. Leonard A. Mechanisms in metal genotoxicity: the significance of in vitro approaches. Mutat Res 1988; 198: 321-326.
88. International Agency for Research on Cancer. Lead and lead compounds. In: IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Lyon, France: IARC, 1980; 23: 325-415.
89. Kasprzak KS, Hoover KL, Poirier LA. Effects of dietary calcium acetate on lead subacetate carcinogenicity in kidneys of male Sprague-Dawley rats. Carcinogenesis 1985; 6: 279-282.
90. Fowler BA, DuVal G. Effects of lead on the kidney: roles of high-affinity lead-binding proteins. Environ Health Perspect 1991; 91: 77-80.
91. Mistry P, Lucier GW, Fowler BA. High-affinity lead binding proteins in rat kidney cytosol mediate cell-free nuclear translocation of lead. J Pharmacol Exp Ther 1985; 232: 462-469.
92. Fowler BA, Kahng MW, Smith DR. Role of lead-binding proteins in renal cancer. Environ Health Perspect 1994; 102 Suppl 3: 115-116.
93. Fowler BA, Mistry P, Victery W. Ultrastructural morphometric studies of lead inclusion body formation in kidney proximal tubules cells: relationship to altered renal protein synthetic patterns. Toxicologist 1985; 5: 53. [Abstract]
94. International Agency for Research on Cancer. Beryllium, cadmium, and mercury exposures in the glass manufacturing industry. In: IARC Monograph on the Evaluation of Carcinogenic Risks to Humans, Vol. 58. Lyon, France: IARC, 1993.
95. Mitsumori K, Hirano M, Ueda H, Maita K, Shirasu Y. Chronic toxicity and carcinogenicity of methylmercury chloride in B6C3F1 mice. Fundam Appl Toxicol 1990; 14: 179-190.
96. Boffetta P, Merler E, Vainio H. Carcinogenicity of mercury and mercury compounds. Scand J Work Environ Health 1993; 19: 1-7.
97. Ellingsen DG, Andersen A, Nordhagen HP, Efskind J, Kjuus H. Incidence of cancer and mortality among workers exposed to mercury vapour in the Norwegian chloralkali industry. Brit J Ind Med 1993; 50: 875-880.
98. Ariza ME, Holliday J, Williams MV. Mutagenic effect of mercury (II) in eukaryotic cells. In Vivo 1994; 8: 559-563.
99. International Agency for Research on Cancer. Nickel and nickel compounds (Group1). In: IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: IARC, 1987; Suppl 7: 264-269.
100. Shen HM, Zhang QF. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 1994; 102 Suppl 1: 275-282.
101. International Agency for Research on Cancer. Chromium, nickel and welding. In: IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: IARC, 1990; 49: 1-677.
102. Cangul H, Broday L, Salnikow K, Sutherland J, Peng W, Zhang Q, et al. Molecular mechanisms of nickel carcinogenesis. Toxicol Lett 2002; 127: 69-75.
103. Kargacin B, Klein CB, Costa M. Mutagenic responses of nickel oxides and nickel sulfides in Chinese hamster V79 cell lines at the xanthineguanine phosphoribosyl transferase locus. Mutat Res 1993; 300: 63-72.
104. Dubins J, Lavelle J. Nickel (II) genotoxicity: potentiation of mutagenesis of simple alkylating agents. Mutat Res 1986; 162: 187-199.
105. Christie NT. The synergistic interaction of Ni(II) with DNA damaging agents. Toxicol Environ Chem 1989; 22: 51-59.
106. Hartwig A, Krueger I, Beyersmann D. Mechanisms in nickel genotoxicity: the significance of interactions with DNA repair. Toxicol Lett 1994; 72: 353-358. Review.
107. Chin YE, Snow ET, Cohen M, Christie NT. (Kinetic analysis of Ni(II) effects on polymerase a. UCLA Symposium on Genomic Instability, Tamarron, CO. J Cell Biochem 1991; 15D, 114.
108. Kawanishi S, Inoue S, Yamamoto K. Site-specific DNA damage by nickel (II) ion in the presence of hydrogen peroxide. Carcinogenesis 1989; 12: 2231-2235.
109. Lee YW, Klein CB, Kargacin B, Salnikow K, Kitahara J, Dowjat K, et al. Carcinogenic nickel silences gene expression by chromosome condensation and DNA methylation: A new model for epigenetic carcinogens. Mol Cell Biol 1995; 15: 2547-2557.
110. Costa M. Conference contribution: Molecular biology of nickel carcinogenesis. Fresenius J Anal Chem 1998; 361: 381-385.
111. Lee YW, Broday L, Costa M. Effects of nickel on DNA methyltransferase and genomic DNA methylation levels. Mutat Res 1998; 415: 213-218.
112. Klein CB, Conway K, Wang XW, Bhamra RK, Lin XH, Cohen MD, et al. Senescence of nickel-transformed cells by an X chromosome: possible epigenetic control. Science 1991; 251: 796-799.
113. Klein CB, Costa M. DNA methylation, heterochromatin and epigenetic carcinogens. Mutat Res 1997; 386: 163-180.
114. Nordberg GF, Anderson O. Metal interactions in carcinogenesis: enhancement, inhibition. Environ Health Perpect 1981; 40: 65-81. Review.
115. Nordberg GF, Pershagen G. Metal interactions in carcinogenesis: effects of mixed exposures on carcinogenic response. Toxicol Environ Chem 1984; 9: 63-78.
116. Nordberg G, Pershagen G. Metal interactions in carcinogenesis. Effects of mixed exposures on carcinogenic response. In: Merian E, Frei R, Hardi W, Schlatter C, eds, Carcinogenic and Mutagenic Metal Compounds: Environmental and Analytical Chemistry and Biological Effects. New York: Gordon & Breach Science Publishers, 1985; 491-506.
117. Pershagen G, Elinder CG, Bolander AM. Mortality in a region surrounding an arsenic emitting plant. Environ Health Perspect 1977; 19: 133-137.
118. Nordberg GF, Wester PO, Brune D. Tissue levels of 25 elements in smelter workers. Proc Int Symp on the Control of Air Pollution in the Working Environment. Stockholm, Sweden: Liber Tryck, 1978; 261-272.
119. Gerhardsson L, Brune D, Nordberg GF, Wester PO. Multielemental assay of tissues of deceased smelter workers and controls. Sci Total Environ 1988; 74: 97-110.
120. International Agency for Research on Cancer. Monograph on the Evaluation of Carcinogenic Risks to Humans - Overall Evaluations of Carcinogenicity: An Update of IARC Monographs. Vols. 1 to 42, Suppl 7. Lyon, France: IARC, 1987.
121. Stern RM. Assessment of risk for lung cancer for workers. Arch Environ Health 1983; 38: 148-155.
122. Flechsig R. What do we know today about welding-fume effects on the respiratory system? Ind Health 1988; 26: 93-100. Review.
123. Becker N, Claude J, Frentzel-Beyme R. Cancer risk of arc welders exposed to fumes containing chromium and nickel. Scand J Work Environ Health 1985; 11: 75-82.
124. Kuper CF, Woutersen RA, Slootweg PJ, Feron VJ. Carcinogenic response of the nasal cavity to inhaled chemical mixtures. Mutat Res 1997; 380: 19-26.
125. Waalkes MP, Rehm S, Kasprzak KS, Issaq HJ. Inflammatory, proliferative, and neoplastic lesions at the site of metallic identification ear tags in Wistar [Crl:(WI)BR] rats. Cancer Res 1987; 47: 2445-2450.
126. Sunderman FW Jr. Carcinogenicity of metal alloys in orthopedic prostheses: clinical and experimental studies. Fund Appl Toxicol 1989; 13: 205-216.
127. Sunderman FW Jr, Hopfer SM, Swift T, Rezuke WN, Ziebka L, Highman P, et al. Cobalt, chromium, and nickel concentrations in body fluids of patients with porous-coated knee or hip prostheses. J Orthop Res 1989; 7: 307-315.
128. Jennings TA, Peterson L, Axiotis CA, Friedlaender GE, Cooke RA, Rosai J. Angiosarcoma associated with foreign body material: A report of three cases. Cancer 1988; 62: 2436-2444.
129. Smith CJ, Livingston SD, Doolittle DJ. An international literature survey of 'IARC group I carcinogens' reported in mainstream cigarette smoke. Food Chem Toxicol 1997; 35: 1107-1130.
130. Wingren G, Axelson O. Epidemiologic studies of occupational cancer as related to complex mixtures of trace elements in the art glass industry. Scand J Work Environ Health 1993; 19 Suppl 1: 95-100. Review.
131. Roig-Navarro AF, Lopez FJ, Serrano R, Hernandez F. An assessment of heavy metals and boron contamination in workplace atmospheres from ceramic factories. Sci Total Environ 1997; 201: 225-234.
132. Kasprzak KS, Waalkes MP. The role of calcium, magnesium, and zinc in carcinogenesis. Adv Exp Med Biol 1986; 206: 497-515.
133. Beyersmann D. Interactions in metal carcinogenicity. Toxicol Lett 1994; 72: 333-338.
134. Waalkes MP. Cadmium carcinogenesis in review. J Inorg Biochem 2000; 79: 241-244.
135. Waalkes MP, Rehm S, Riggs CW, Bare RM, Devor DE, Poirier LA, et al. Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: Dose-response analysis of effects of zinc on tumor induction in the prostate, in the testes, and at the injection site. Cancer Res 1989; 49: 4282-4288.
136. Brzóska MM, Moniuszko-Jakoniuk J. Interactions between cadmium and zinc in the organism. Food Chem Toxicol 2001; 39: 967-980.
137. Beyersmann D. The significance of interactions in metal essentiality and toxicity. In: Merian E, ed, Metals and Their Compounds in the Environment. Weinheim, Germany: VCH, 1991; 491-509.
138. Kasprzak KS, Quander RV, Poirier LA. Effects of calcium and magnesium salts on nickel subsulfide carcinogenicity in Fischer rats. Carcinogenesis 1985; 6: 1161-1166.
139. Sirover MA, Loeb LA. Infidelity of DNA synthesis in vitro: screening for potential metal mutagens or carcinogens. Science 1976; 194 (4272): 1434-1436.
140. Simons TJ, Pocock G. Lead enters adrenal medullary cells through calcium channels. J Neurochem 1987; 48: 383-389.
141. Goyer RA. Nutrition and metal toxicity. Am J Clin Nutr 1995; 61 (3 Suppl): 646S-650S. Review.
142. Planas-Bohne F, Klug S. Uptake of cadmium into cells in culture. Toxicol Environ Chem 1988; 18: 229-237.
143. Sorensen EM, Smith NK, Boecker CS, Acosta D. Calcium amelioration of cadmium-induced cytotoxicity in cultured rat hepatocytes. In Vitro 1984; 20: 771-779.
144. 2+-dependent endonuclease in apoptosis. Biochem Biophys Res Commun 1993; 190: 1097-1103.
145. Hengstler JG, Bolm-Audorff U, Faldum A, Janssen K, Reifenrath M, Götte W, et al. Occupational exposure to heavy metals: DNA damage induction and DNA repair inhibition prove co-exposures to cadmium, cobalt and lead as more dangerous than hitherto expected. Carcinogenesis 2003; 24: 63-73.
146. Beckman L, Nordenson I. Interaction between some common genotoxic agents. Hum Hered 1986; 36: 397-401.
147. Beyersmann D, Hartwig A. Combined effects of carcinogenic metal compounds. Ergo-Med 1999; 23: 170-175.
148. Witschi HR, Munro NB. The problems of toxicological testing of complex mixtures. Developments in toxicology and environmental science. Dev Toxicol Environ Sci. 1983; 11: 3-11.
149. Waalkes MP, Coogan TP, Barter RA. Toxicological principles of metal carcinogenesis with special emphasis on cadmium. Crit Rev Toxicol 1992; 22: 175-201.
150. Goldsworthy TL, Recio L, Brown K, Donehower LA, Mirsalis JC, Tennant RW, Purchase IF. Transgenic animals in toxicology. Fund Appl Toxicol 1994; 22: 8-19.
151. Gibb H, Chen C. Risk assessment of complex mixtures. In: Waters MD, Sandhu SS, Lewtas J, Claxton L, Strauss G, Nesnow S, eds, Short-Term Bioassays in the Analysis Of Complex Environmental Mixtures IV. Plenum Press. Environmental Science Research, Vol. 32. New New York, NY, USA: Plenum Press, 1985; 353-361.